Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;79(10):2148-2158.
doi: 10.1161/HYPERTENSIONAHA.122.19414. Epub 2022 Jun 21.

Digital Therapeutics in Hypertension: Evidence and Perspectives

Affiliations
Review

Digital Therapeutics in Hypertension: Evidence and Perspectives

Kazuomi Kario et al. Hypertension. 2022 Oct.

Abstract

Digital therapeutics refers to the use of evidence-based therapeutic interventions driven by high-quality software programs to treat, manage, or prevent a medical condition. This approach is being increasingly investigated for the management of hypertension, a common condition that is the leading preventable cardiovascular disease risk factor worldwide. Digital interventions can help facilitate uptake of important guideline-recommended lifestyle modifications, reinforce home blood pressure monitoring, decrease therapeutic inertia, and improve medication adherence. However, current studies are only of moderate quality, and are highly heterogeneous in the interventions evaluated, comparator used, and results obtained. Therefore, additional studies are needed, focusing on the development of universally applicable and consistent digital therapeutic strategies designed with health care professional input and evaluation of these interventions in robust clinical trials with objective end points. Hopefully, the momentum for digital therapeutics triggered by the coronavirus disease 2019 pandemic can be utilized to maximize advancements in this field and drive widespread implementation.

Keywords: blood pressure; cardiovascular diseases; digital technology; hypertension; mobile applications.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Key definitions and keywords. DTx indicates digital therapeutics; and ICT, information and communications technology.
Figure 2.
Figure 2.
Components of a theoretical digital therapeutics platform for hypertension: interactive approach for optimized personalized intervention. BP, blood pressure.
Figure 3.
Figure 3.
Digital therapeutics process for hypertension (lifestyle modifications based on personalized analysis). BP indicates blood pressure.
Figure 4.
Figure 4.
Potential mechanisms contributing to the blood pressure (BP)–lowering effects of digital therapeutic interventions for hypertension, including lifestyle modifications (blue boxes), BP monitoring (purple box), and optimization of pharmacological therapy (black boxes). DTx indicates digital therapeutics.
Figure 5.
Figure 5.
Digital therapeutics as one component of patient-centered hypertension management.

References

    1. World Health Organization. WHO guideline: recommendations on digital interventions for health system strengthening. Geneva, 2019. Accessed May 11, 2022. https://www.who.int/publications/i/item/9789241550505 - PubMed
    1. Marques ICP, Ferreira JJM. Digital transformation in the area of health: systematic review of 45 years of evolution. Health and Technology. 2020;10:575–586. doi: 10.1007/s12553-019-00402-8
    1. Digital Therapeutics Alliance. Digital Therapeutics Definitin and Core Principles (Nov 2019). Accessed November 22, 2021. https://dtxalliance.org/wp-content/uploads/2021/01/DTA_DTx-Definition-an...
    1. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016;4:Cd006611. doi: 10.1002/14651858.CD006611.pub4 - PMC - PubMed
    1. Linardon J, Cuijpers P, Carlbring P, Messer M, Fuller-Tyszkiewicz M. The efficacy of app-supported smartphone interventions for mental health problems: a meta-analysis of randomized controlled trials. World Psychiatry. 2019;18:325–336. doi: 10.1002/wps.20673 - PMC - PubMed